EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Unveiling the Prognostic Role of Synaptophysin in Conventional Colorectal Carcinomas

Giovanna Sabella, Giovanni Centonze, Vincenzo Lagano, Andrea Scardino, Filiberto Belli, Giovanna Garzone, Carlotta Pardo, Daniela Galbiati, Sara Pusceddu, Alessandro Mangogna, Valentina Angerilli, Matteo Fassan und 10 weitere

Neuroendocrinology · 05.05.2025 · 115 (8) · 632-647

DOI: 10.1159/000545979 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuroendocrinology, online erschienen am 05.05.2025. Verfasst von Giovanna Sabella und 21 weiteren Autor:innen. Beteiligte Einrichtung: 1st Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Synaptophysin, Adenocarcinoma. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although neuroendocrine differentiation in colorectal carcinomas (CRCs) has been extensively reported, the biological behavior of adenocarcinomas expressing synaptophysin (Syn) but lacking typical neuroendocrine morphology remains unclear.

Methods

We tested 663 conventional CRCs with non-neuroendocrine morphology for Syn expression and correlated the results with clinicopathological and molecular characteristics as well as patient survival (overall survival [OS] and disease-free survival [DFS]). The survival characteristics of Syn expression group were compared to those of conventional CRCs and subsequently to those of 14 minENs.

Results

Syn immunohistochemical expression ≥30% was confirmed in 27 (4.1%) patients and correlated with right colon site, grade 2, marked intratumoral lymphocyte infiltrate, and BRAF p.V600E mutation. At univariate analysis, variables associated with poor OS were 10-year increase in age (p = 0.001), stage III–IV (p = 0.001), Syn ≥30% (p = 0.001), infiltrative growth (p = 0.04), and residual tumor R1–2 (p = 0.03). At multivariable analysis, Syn expression in ≥30% of gland-forming tumor cells emerged as an independent negative prognostic factor for both OS and DFS. Moreover, 10-year increase in age, stage III–IV, and Syn ≥30% (p < 0.001) were associated with poor OS and marked peritumoral lymphocyte infiltrate with longer OS (p = 0.02). Comparable results were obtained according to DFS; in addition, right colon site (p = 0.04) was associated with longer DFS while KRAS mutation (p = 0.04) was associated with poor DFS at univariate analysis. MiNEN patients showed a shorter DFS than all conventional adenocarcinomas with or without Syn expression in univariate analyses (p < 0.001).

Conclusions

Among conventional CRCs, we provided evidence that Syn expression is associated with worse OS and DFS and contributes to predicting clinical outcome. Future studies should explore the molecular mechanisms underlying the acquisition of the neuroendocrine phenotype to identify new targeted treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsSynaptophysinAdenocarcinomaHumansMaleFemaleMiddle AgedPrognosisAgedAdultAged, 80 and overDisease-Free SurvivalBiomarkers, Tumor

Stichwörter der Autor:innen

Amphicrine tumorColorectal carcinomaImmunohistochemistryNeuroendocrine tumorPrognostic markersSynaptophysin

Substanzen

SynaptophysinBiomarkers, Tumor

Autor:innen und Institutionen

  • 1st Pathology Division, Department of Pathology and Laboratory Medicine, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Colorectal Surgery Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Department of Medicine (DMED), Institute of Pathological Anatomy, University of Udine, Udine, Italy.
  • Department of Life Sciences, University of Trieste, Trieste, Italy.
  • Department of Medicine (DIMED), University of Padua, Padua, Italy.

Zitieren

APA

Sabella, G., Centonze, G., Lagano, V., Scardino, A., Belli, F., Garzone, G., Pardo, C., Galbiati, D., Pusceddu, S., Mangogna, A., Angerilli, V., Fassan, M., Vingiani, A., Agnelli, L., Pruneri, G., Gobba, S., Uccella, S., La Rosa, S., Sessa, F., …, & Milione, M. (2025). Unveiling the Prognostic Role of Synaptophysin in Conventional Colorectal Carcinomas. Neuroendocrinology, 115(8), 632-647. https://doi.org/10.1159/000545979

Vancouver

Sabella G, Centonze G, Lagano V, Scardino A, Belli F, Garzone G, et al. Unveiling the Prognostic Role of Synaptophysin in Conventional Colorectal Carcinomas. Neuroendocrinology. 2025;115(8):632-647. doi:10.1159/000545979

BibTeX
@article{Sabella2025,
  author = {Sabella, Giovanna and Centonze, Giovanni and Lagano, Vincenzo and Scardino, Andrea and Belli, Filiberto and Garzone, Giovanna and Pardo, Carlotta and Galbiati, Daniela and Pusceddu, Sara and Mangogna, Alessandro and Angerilli, Valentina and Fassan, Matteo and Vingiani, Andrea and Agnelli, Luca and Pruneri, Giancarlo and Gobba, Stefania and Uccella, Silvia and La Rosa, Stefano and Sessa, Fausto and Capella, Carlo and Milione, Massimo and Milione, Massimo},
  title = {Unveiling the Prognostic Role of Synaptophysin in Conventional Colorectal Carcinomas},
  journal = {Neuroendocrinology},
  year = {2025},
  volume = {115},
  number = {8},
  pages = {632--647},
  doi = {10.1159/000545979}
}
Kostenlos starten →